Lipids and lipoproteins in persons with Down's syndrome

Journal of Intellectual Disability Research - Tập 36 Số 4 - Trang 365-369 - 1992
S. M. Pueschel1, Wendy Y. Craig1, James E. Haddow1
1Child Development Center, Department of Pediatrics, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island, and The Foundation for Blood Research, Scarborough, Maine, USA

Tóm tắt

ABSTRACT. This study was designed to investigate whether the observed decreased prevalence of coronary artery disease in individuals with Down's syndrome may be explained by their serum lipid and lipoprotein profiles. Twentyseven persons with Down's syndrome and 23 non‐afiFected control individuals were enrolled in this study. Their fasting venous blood was analysed for total cholesterol, triglyceride, LDH cholesterol, HDL cholesterol, apo B and apo AI. The results revealed no significant differences between the study and control group with regard to total cholesterol, LDL cholesterol, apo B and the apo B:apo AI ratio. However, triglyceride levels were significantly increased, and serum HDL cholesterol, apo AI and HDL cholesterohtotal cholesterol ratio were significantly decreased in patients with Down's syndrome when compared with the control group. The latter observations are all associated with an increased risk for coronary artery disease. Therefore, it is concluded that the decreased prevalence of coronary artery disease in individuals with Down's syndrome carmot be explained by the lipid and lipoprotein levels observed in this study population.

Từ khóa


Tài liệu tham khảo

10.1016/0009-8981(88)90265-3

10.1016/S0140-6736(87)91772-7

10.1016/0002-8703(83)90174-6

Chaney R.H, 1987, Neurogenic atherosclerosis in mentally retarded persons, Journal of Mental Deficiency Research, 3, 235

10.1016/0009-8981(84)90267-5

Friedewald W. T., 1972, Estimation of the concentration of low density lipoprotein cholesterol without use of the preparative ultracentrifuge, Clinical Chemistry, 18, 499, 10.1093/clinchem/18.6.499

10.1016/0002-9343(77)90874-9

Heiss G., 1983, Proceedings of the workshop on apolipoprotein quantification, 7

10.1016/S0140-6736(75)92376-4

Moss T. J., 1980, Pre‐atherosclerotic lesions in Down's syndrome, Journal of Mental Deficiency Research, 24, 137

10.1136/bmj.2.6081.226

10.3109/00365517909106135

Warnick G. R., 1985, Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol, Clinical Chemistry, 31, 217, 10.1093/clinchem/31.2.217

10.1016/0021-9150(89)90110-X